XML 24 R9.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Operating Activities:    
Net loss $ (684,796) $ (651,870)
Adjustments to reconcile net loss to net cash flows used in operating activities:    
Depreciation and amortization 74,540 58,244
Non-cash interest expense 931 775
Stock-based compensation expense 322,598 323,582
Loss from equity method investment 2,429 347
(Gain) loss on remeasurement of warrant liabilities (26,996) 9,996
Gain on equity securities and other financial assets (31,808) 0
Deferred income taxes (76,656) (9,548)
Other expenses, net (2,667) 0
Change in operating assets and liabilities, net of effect of business combinations:    
Receivables reserved for users (2,057) 5,334
Accounts receivable 9,765 (993)
Prepaid expenses and other current assets (47,574) (9,136)
Deposits and other non-current assets (135) (2,944)
Operating leases, net 240 (432)
Accounts payable and accrued expenses (15,659) 73,309
Other long-term liabilities 5,003 1,883
Long-term income tax liability (5,266) 3,874
Liabilities to users (51,195) 21,204
Net cash flows used in operating activities (529,303) (176,375)
Investing Activities:    
Purchases of property and equipment (14,457) (6,221)
Cash paid for internally developed software costs (29,419) (19,489)
Acquisition of gaming licenses (3,388) (6,200)
Cash paid for acquisitions, net of cash acquired (96,507) (64,969)
Other investing activities (3,697) (3,700)
Net cash flows used in investing activities (147,468) (100,579)
Financing Activities:    
Proceeds from issuance of convertible notes, net 0 1,247,125
Purchase of capped call options 0 (123,970)
Proceeds from shares issued for warrants 44 199
Purchase of treasury stock (17,476) (9,897)
Proceeds from exercise of stock options 4,901 18,454
Net cash flows (used in) provided by financing activities (12,531) 1,131,911
Effect of foreign exchange rates on cash and cash equivalents and restricted cash 0 824
Net (decrease) increase in cash and cash equivalents and restricted cash (689,302) 855,781
Cash and cash equivalents and restricted cash at the beginning of period 2,629,842 2,104,976
Cash and cash equivalents and restricted cash, end of period 1,940,540 2,960,757
Disclosure of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 1,514,371 2,646,500
Cash reserved for users 426,169 314,257
Total cash, cash equivalents and restricted cash, end of period 1,940,540 2,960,757
Supplemental Disclosure of Noncash Investing and Financing Activities:    
Equity consideration issued for acquisitions 460,128 33,149
Acquisition of property and equipment, internally developed software and other investments included in accounts payable and accrued expenses 9,425 (114)
Convertible notes financing costs included in accounts payable and accrued expenses 0 782
Acquisition of gaming licenses included in accounts payable and accrued expenses 0 (4,976)
Increase of other current assets from transfer agent related to warrants 0 494
Supplemental Disclosure of Cash Activities:    
(Decrease) increase in cash reserved for users (50,781) 26,539
Cash paid for interest $ 0 $ 0